ArticleJOM (Warrendale, Pa. : 1989)2025
Polydopamine-based Surface Modifications for Tissue Engineering and Biosensing: From Understanding Chemistry to Diverse Applications.
Article in JOM (Warrendale, Pa. : 1989), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nanoparticle type-dependent regulation of polydopamine coating formation and wettability.RSC advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
In 2007, researchers were intrigued with how effectively saltwater mussels were able to attach to seemingly any surface, looked further into how this was possible, and developed polydopamine (PDA). The polymerized form of a common neurotransmitter, dopamine, PDA adhesive protein has become known as a powerful biomaterial with broad applications in tissue engineering, drug delivery, biosensing, and antibacterial technologies. Its robust adhesion, due to catechol and amine groups, allows uniform coating on various types of surfaces and enhances properties such as bioactivity, corrosion resistance, and mechanical strength. In this review paper, we aim to look at the last 17 years of research around PDA and to examine its applications, particularly in the biomedical field. Additionally, we have focused on how 3D printing and incorporation into biosensing devices could allow for an even wider range of manufactured products within the biomedical industry that use PDA as a primary component. PDA-coated 3D-printed scaffolds show great biocompatibility and osteogenic potential, providing innovative solutions for bone, neural, and cardiac tissue engineering. In drug delivery, PDA enables controlled release and photothermal therapies, enhancing cancer treatment precision while decreasing side effects. PDA's antibacterial efficacy and biosensing applications are also discussed.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.